Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Transplantation|December 13, 2005
High body mass index and short- and long-term renal allograft survival in adultsNader N Massarweh, John L Clayton, Craig A Mangum, et al.
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society|March 13, 2009
Resection of a large, ruptured, undifferentiated (embryonal) sarcoma of the liver in a child: a case report and review of the literatureDavid C Yu, Ravi Tandon, Angela K Bohlke, et al.
Southern Medical Journal|December 20, 2007
Living donor kidney transplantation: medical, legal, and ethical considerationsAnil S Paramesh, Mary T Killackey, Rubin Zhang, et al.
Hepatology (Baltimore, Md.)|August 8, 2014
Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantationShunji Nagai, Atsushi Yoshida, Marcelo Facciuto, et al.
Journal of Robotic Surgery|September 2, 2017
Robotic-assisted vs. laparoscopic donor nephrectomy: a retrospective comparison of perioperative course and postoperative outcome after 1 yearAnthony Yang, Naman Barman, Edward Chin, et al.
Transplantation|January 16, 2004
Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantationAnil S Paramesh, Celia Grosskreutz, Sander S Florman, et al.
Clinical Transplantation|December 7, 2019
Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C-negative recipients: A single-center studyJames F Crismale, Mian Khalid, Arjun Bhansali, et al.
Journal of the American College of Surgeons|March 31, 2004
Anatomic variations in right liver living donorsGiovanni Varotti, Gabriel E Gondolesi, Jeffrey Goldman, et al.
Journal of Hepatology|February 21, 2013
WITHDRAWN: Recurrence prediction of hepatocellular carcinoma after liver transplantation by ischemia time and tumor characteristicsShunji Nagai, Marcelo Facciuto, Shozo Mori, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 27, 2021
Outcomes of transplantation for HBV- vs. HCV-related HCC: impact of DAA HCV therapy in a national analysis of >20,000 patientsParissa Tabrizian, Behnam Saberi, Matthew L Holzner, et al.
Pageof 8